This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||
|
The contents of the Granulysin page were merged into GNLY. For the contribution history and old versions of the redirected page, please see its history; for the discussion at that location, see its talk page. |
This article was the subject of a Wiki Education Foundation-supported course assignment, between 5 January 2022 and 11 March 2022. Further details are available on the course page. Student editor(s): Immcarle181 (article contribs).
Bibliography Immcarle153
edit[1] [2] [3] [4] Immcarle153 (talk) 23:36, 29 January 2021 (UTC)
References
- ^ Dotiwala, Farokh; Lieberman, Judy (October 2019). "Granulysin: killer lymphocyte safeguard against microbes". Current Opinion in Immunology. 60: 19–29. doi:10.1016/j.coi.2019.04.013.
- ^ Harris, Victoria; Jackson, Christopher; Cooper, Alan (18 December 2016). "Review of Toxic Epidermal Necrolysis". International Journal of Molecular Sciences. 17 (12): 2135. doi:10.3390/ijms17122135.
{{cite journal}}
: CS1 maint: unflagged free DOI (link) - ^ Liu, Xing; Lieberman, Judy (26 April 2020). "Knocking 'em Dead: Pore-Forming Proteins in Immune Defense". Annual Review of Immunology. 38 (1): 455–485. doi:10.1146/annurev-immunol-111319-023800.
- ^ Sparrow, E.; Bodman-Smith, M. D. (1 January 2020). "Granulysin: The attractive side of a natural born killer". Immunology Letters. 217: 126–132. doi:10.1016/j.imlet.2019.11.005.